 Home > Active Ingredient News > Drugs Articles > The new indication of WuXi Junuo CAR-T therapy for the treatment of follicular lymphoma is planned to be included in priority review

The new indication of WuXi Junuo CAR-T therapy for the treatment of follicular lymphoma is planned to be included in priority review

 Last Update: 2022-04-29
 Source: Internet
 Author: User

Tags

therapy

figo grade 1

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 24, the CDE official website recently showed that the new indication of WuXi Junuo CAR-T therapy Ruikiorenzae injection is to be included in the priority review
.

The newly added indication for this application is: adult relapsed or refractory follicular lymphoma after second-line or above systemic therapy, including follicular lymphoma with histological grades 1, 2, and 3a

It is reported that the previously approved indications are: adult patients with relapsed or refractory large B-cell lymphoma after second-line or above systemic therapy, including diffuse large B-cell lymphoma unspecified, follicular lymphoma transformed Diffuse large B-cell lymphoma, grade 3b follicular lymphoma, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma with MYC and BCL-2 and/or BCL-6 rearrangements (double hit/triple hit fight lymphoma)
.

Ruiji Orenxai Injection (formerly known as Ruijilunxi Injection) is an anti-CD19 CAR-T product developed by WuXi Junuo, and it is also the core candidate product of WuXi Junuo
.

CD19 is a specific antigen expressed on the surface of B cells

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.